Literature DB >> 14581108

Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis.

Diane C Zelman1, Deborah L Hoffman, Raafat Seifeldin, Ellen M Dukes.   

Abstract

The objective of this study was to adapt the concept of 'episode-free day', a metric for measuring symptom relief in daily units, to the clinical outcome literature for persistent pain. The episode-free day metric is widely used in other medical literature, but no analogous measure exists in pain literature. Prior focus groups with this population suggested that a 'Day of Manageable Pain Control' was an appropriate name for the metric. In the present study, in order to derive a statistical criterion for 'Manageable Day', we used Serlin et al.'s (Pain 61 (1995) 277) cut-point derivation method to derive a single cut-point on a 0-10 scale of average pain that divided groups with significant persistent pain optimally on pain-related functional interference. Participants were 194 patients with moderate-severe low back pain (n=96) or osteoarthritis (n=98). For both patient samples, '5' was the cut-point that optimally distinguished groups on pain-related interference. '5-8' and '5-7' were double cut-point solutions that optimally divided LBP and OA samples into three categories (e.g. lowest, medium and highest average pain), respectively. Derived cut-points were confirmed using a variety of measures of functional disability. Together with research that showed that average pain ratings of approximately 5 and below permit increased function and quality of life in patients with moderate to severe low back pain and osteoarthritis, our findings provide support for the use of 0-5 on a 0-10 numeric average pain severity scale as one possible criterion for a Manageable Day.

Entities:  

Mesh:

Year:  2003        PMID: 14581108     DOI: 10.1016/s0304-3959(03)00274-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  38 in total

1.  Which pain intensity scale from the Brief Pain Inventory correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia?

Authors:  Nicholas Chiu; Liying Zhang; Daniela Gallo-Hershberg; Rebecca Dent; Leonard Chiu; Mark Pasetka; Jenna van Draanen; Ronald Chow; Henry Lam; Sunil Verma; Jordan Stinson; Erica Stacey; Edward Chow; Carlo DeAngelis
Journal:  Support Care Cancer       Date:  2016-02-11       Impact factor: 3.603

2.  Chronic pain severity in opioid-dependent patients.

Authors:  Jennifer S Potter; Sara J Shiffman; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

3.  Does preoperative risk for delirium moderate the effects of postoperative pain and opiate use on postoperative delirium?

Authors:  Jacqueline M Leung; Laura P Sands; Eunjung Lim; Tiffany L Tsai; Sakura Kinjo
Journal:  Am J Geriatr Psychiatry       Date:  2013-05-06       Impact factor: 4.105

4.  [What does pain intensity mean from the patient perspective? : A qualitative study on the patient perspective of pain intensity as an outcome parameter in treatment evaluation and on the interpretability of pain intensity measurements].

Authors:  K Neustadt; S Deckert; C Kopkow; A Preißler; B Bosse; C Funke; L Jacobi; P Mattenklodt; B Nagel; P Seidel; R Sittl; E Steffen; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

5.  Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers.

Authors:  Karon F Cook; David E Victorson; David Cella; Benjamin D Schalet; Deborah Miller
Journal:  Qual Life Res       Date:  2014-08-23       Impact factor: 4.147

6.  Smoking and female sex as key risk factors associated with severe arthralgia in acute and chronic phases of Chikungunya virus infection.

Authors:  Ivan Delgado-Enciso; Brenda Paz-Michel; Valery Melnikov; Jose Guzman-Esquivel; Francisco Espinoza-Gomez; Alejandro D Soriano-Hernandez; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Gabriel Ceja-Espiritu; Bertha A Olmedo-Buenrostro; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Josuel Delgado-Enciso; Uriel A Lopez-Lemus; Daniel A Montes-Galindo
Journal:  Exp Ther Med       Date:  2017-12-21       Impact factor: 2.447

7.  Pain in patients with borderline personality disorder.

Authors:  Robert S Biskin; Frances R Frankenburg; Garrett M Fitzmaurice; Mary C Zanarini
Journal:  Personal Ment Health       Date:  2014-07-15

8.  Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?

Authors:  Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Pain Symptom Manage       Date:  2007-12-26       Impact factor: 3.612

9.  Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity.

Authors:  Alesia B Sadosky; Andrew G Bushmakin; Joseph C Cappelleri; David R Lionberger
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

10.  Comparing fibromyalgia patients from primary care and rheumatology settings: clinical and psychosocial features.

Authors:  Ana Lledó Boyer; Maria Angeles Mira Pastor; Nieves Pons Calatayud; Sofía Lopez-Roig; Maria Carmen Cantero Terol
Journal:  Rheumatol Int       Date:  2008-12-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.